SPAREBANKEN NORGE (SBNOR.OL) Stock Fundamental Analysis
OSL:SBNOR - Euronext Oslo - NO0006000900 - Common Stock - Currency: NOK
Taking everything into account, SBNOR scores 4 out of 10 in our fundamental rating. SBNOR was compared to 91 industry peers in the Banks industry. SBNOR has a medium profitability rating, but doesn't score so well on its financial health evaluation. SBNOR has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
SBNOR had positive earnings in the past year.
In the past year SBNOR had a positive cash flow from operations.
SBNOR had positive earnings in each of the past 5 years.
Each year in the past 5 years SBNOR had a positive operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of 0.56%, SBNOR is in line with its industry, outperforming 41.76% of the companies in the same industry.
SBNOR has a Return On Equity of 7.67%. This is comparable to the rest of the industry: SBNOR outperforms 40.66% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.56% | ||
| ROE | 7.67% | ||
| ROIC | N/A |
ROA(3y)0.49%
ROA(5y)0.45%
ROE(3y)6.19%
ROE(5y)5.61%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
SBNOR's Profit Margin of 23.18% is fine compared to the rest of the industry. SBNOR outperforms 60.44% of its industry peers.
SBNOR's Profit Margin has improved in the last couple of years.
The Operating Margin and Gross Margin are not available for SBNOR so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | 23.18% | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y12.59%
PM growth 5Y16.7%
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
SBNOR does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for SBNOR remains at a similar level compared to 1 year ago.
Compared to 5 years ago, SBNOR has more shares outstanding
The debt/assets ratio for SBNOR is higher compared to a year ago.
2.2 Solvency
SBNOR has a debt to FCF ratio of 41.53. This is a negative value and a sign of low solvency as SBNOR would need 41.53 years to pay back of all of its debts.
SBNOR has a Debt to FCF ratio of 41.53. This is in the better half of the industry: SBNOR outperforms 76.92% of its industry peers.
SBNOR has a Debt/Equity ratio of 7.02. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of SBNOR (7.02) is worse than 89.01% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 7.02 | ||
| Debt/FCF | 41.53 | ||
| Altman-Z | N/A |
ROIC/WACCN/A
WACC5.68%
2.3 Liquidity
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | N/A | ||
| Quick Ratio | N/A |
3. Growth
3.1 Past
SBNOR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 21.47%, which is quite impressive.
The Earnings Per Share has been growing by 17.42% on average over the past years. This is quite good.
The Revenue has decreased by -3.93% in the past year.
SBNOR shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.96% yearly.
EPS 1Y (TTM)21.47%
EPS 3Y22.09%
EPS 5Y17.42%
EPS Q2Q%8.64%
Revenue 1Y (TTM)-3.93%
Revenue growth 3Y9.69%
Revenue growth 5Y10.96%
Sales Q2Q%8.77%
3.2 Future
SBNOR is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -1.12% yearly.
Based on estimates for the next years, SBNOR will show a quite strong growth in Revenue. The Revenue will grow by 18.89% on average per year.
EPS Next Y-10.04%
EPS Next 2Y-5.69%
EPS Next 3Y-1.12%
EPS Next 5YN/A
Revenue Next Year44.04%
Revenue Next 2Y27.62%
Revenue Next 3Y18.89%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 9.39, the valuation of SBNOR can be described as reasonable.
SBNOR's Price/Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Earnings ratio of 27.50, SBNOR is valued rather cheaply.
SBNOR is valuated reasonably with a Price/Forward Earnings ratio of 10.80.
SBNOR's Price/Forward Earnings is on the same level as the industry average.
SBNOR is valuated cheaply when we compare the Price/Forward Earnings ratio to 36.44, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.39 | ||
| Fwd PE | 10.8 |
4.2 Price Multiples
82.42% of the companies in the same industry are more expensive than SBNOR, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 6.36 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)0.54
EPS Next 2Y-5.69%
EPS Next 3Y-1.12%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 5.20%, SBNOR is a good candidate for dividend investing.
SBNOR's Dividend Yield is comparable with the industry average which is at 5.19.
Compared to an average S&P500 Dividend Yield of 2.35, SBNOR pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 5.2% |
5.2 History
The dividend of SBNOR is nicely growing with an annual growth rate of 42.04%!
Dividend Growth(5Y)42.04%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
SBNOR pays out 112.92% of its income as dividend. This is not a sustainable payout ratio.
The Dividend Rate of SBNOR has been growing, while earnings will be declining. This means the dividend growth is most likely not sustainable.
DP112.92%
EPS Next 2Y-5.69%
EPS Next 3Y-1.12%
OSL:SBNOR (7/18/2025, 7:00:00 PM)
159.98
-1.78 (-1.1%)
Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)
Earnings (Next)
Inst Owners20.23%
Inst Owner ChangeN/A
Ins Owners0.51%
Ins Owner ChangeN/A
Market Cap27.14B
Analysts78.67
Price Target153.82 (-3.85%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 5.2% |
Yearly Dividend24.37
Dividend Growth(5Y)42.04%
DP112.92%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.88%
Min EPS beat(2)-3.55%
Max EPS beat(2)5.31%
EPS beat(4)3
Avg EPS beat(4)5.86%
Min EPS beat(4)-3.55%
Max EPS beat(4)14.66%
EPS beat(8)6
Avg EPS beat(8)4.43%
EPS beat(12)8
Avg EPS beat(12)12.21%
EPS beat(16)12
Avg EPS beat(16)13.75%
Revenue beat(2)0
Avg Revenue beat(2)-7.09%
Min Revenue beat(2)-13.13%
Max Revenue beat(2)-1.06%
Revenue beat(4)2
Avg Revenue beat(4)0.5%
Min Revenue beat(4)-13.13%
Max Revenue beat(4)8.42%
Revenue beat(8)6
Avg Revenue beat(8)16.3%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.57%
PT rev (3m)N/A
EPS NQ rev (1m)-1.13%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)10.11%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.39 | ||
| Fwd PE | 10.8 | ||
| P/S | 3.25 | ||
| P/FCF | 6.36 | ||
| P/OCF | 6.26 | ||
| P/B | 1.08 | ||
| P/tB | 1.1 | ||
| EV/EBITDA | N/A |
EPS(TTM)17.03
EY10.65%
EPS(NY)14.81
Fwd EY9.26%
FCF(TTM)25.16
FCFY15.73%
OCF(TTM)25.55
OCFY15.97%
SpS49.26
BVpS148.81
TBVpS145.55
PEG (NY)N/A
PEG (5Y)0.54
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.56% | ||
| ROE | 7.67% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | 23.18% | ||
| GM | N/A | ||
| FCFM | 51.08% |
ROA(3y)0.49%
ROA(5y)0.45%
ROE(3y)6.19%
ROE(5y)5.61%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y12.59%
PM growth 5Y16.7%
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.02
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 7.02 | ||
| Debt/FCF | 41.53 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | 0.78% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | 220.36% | ||
| Current Ratio | N/A | ||
| Quick Ratio | N/A | ||
| Altman-Z | N/A |
F-Score5
WACC5.68%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)1.41%
Cap/Sales(5y)1.57%
Profit Quality(3y)228.55%
Profit Quality(5y)217.4%
High Growth Momentum
Growth
EPS 1Y (TTM)21.47%
EPS 3Y22.09%
EPS 5Y17.42%
EPS Q2Q%8.64%
EPS Next Y-10.04%
EPS Next 2Y-5.69%
EPS Next 3Y-1.12%
EPS Next 5YN/A
Revenue 1Y (TTM)-3.93%
Revenue growth 3Y9.69%
Revenue growth 5Y10.96%
Sales Q2Q%8.77%
Revenue Next Year44.04%
Revenue Next 2Y27.62%
Revenue Next 3Y18.89%
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y56.85%
FCF growth 3Y28.27%
FCF growth 5Y61.38%
OCF growth 1Y52.46%
OCF growth 3Y27.09%
OCF growth 5Y18.41%